These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11931671)

  • 41. Serpins of oat (Avena sativa) grain with distinct reactive centres and inhibitory specificity.
    Hejgaard J; Hauge S
    Physiol Plant; 2002 Oct; 116(2):155-163. PubMed ID: 12354191
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A 1H NMR probe for mobility in the reactive center loops of serpins: spin-echo studies of native and modified forms of ovalbumin and alpha 1-proteinase inhibitor.
    Hood DB; Gettins P
    Biochemistry; 1991 Sep; 30(37):9054-60. PubMed ID: 1892818
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of the P2 residue in determining the specificity of serpins.
    Djie MZ; Le Bonniec BF; Hopkins PC; Hipler K; Stone SR
    Biochemistry; 1996 Sep; 35(35):11461-9. PubMed ID: 8784202
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NMR studies of internal dynamics of serine proteinase protein inhibitors: Binding region mobilities of intact and reactive-site hydrolyzed Cucurbita maxima trypsin inhibitor (CMTI)-III of the squash family and comparison with those of counterparts of CMTI-V of the potato I family.
    Liu J; Gong Y; Prakash O; Wen L; Lee I; Huang JK; Krishnamoorthi R
    Protein Sci; 1998 Jan; 7(1):132-41. PubMed ID: 9514268
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of strand 1 of the C beta-sheet in the structure and function of alpha(1)-antitrypsin.
    Bottomley SP; Lawrenson ID; Tew D; Dai W; Whisstock JC; Pike RN
    Protein Sci; 2001 Dec; 10(12):2518-24. PubMed ID: 11714919
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The contribution of arginine residues within the P6-P1 region of alpha 1-antitrypsin to its reaction with furin.
    Dufour EK; Denault JB; Bissonnette L; Hopkins PC; Lavigne P; Leduc R
    J Biol Chem; 2001 Oct; 276(42):38971-9. PubMed ID: 11479287
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Redesigning the reactive site loop of the wheat subtilisin/chymotrypsin inhibitor (WSCI) by site-directed mutagenesis. A protein-protein interaction study by affinity chromatography and molecular modeling.
    Bruni N; Di Maro A; Costantini S; Chambery A; Facchiano AM; Ficca AG; Parente A; Poerio E
    Biochimie; 2009 Sep; 91(9):1112-22. PubMed ID: 19500644
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proteolytic characteristics of cathepsin D related to the recognition and cleavage of its target proteins.
    Sun H; Lou X; Shan Q; Zhang J; Zhu X; Zhang J; Wang Y; Xie Y; Xu N; Liu S
    PLoS One; 2013; 8(6):e65733. PubMed ID: 23840360
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibitory mechanism of serpins. Identification of steps involving the active-site serine residue of the protease.
    Stone SR; Le Bonniec BF
    J Mol Biol; 1997 Jan; 265(3):344-62. PubMed ID: 9018048
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recent progress in understanding the diversity of the human ov-serpin/clade B serpin family.
    Izuhara K; Ohta S; Kanaji S; Shiraishi H; Arima K
    Cell Mol Life Sci; 2008 Aug; 65(16):2541-53. PubMed ID: 18516497
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Structural comparison of two serine proteinase-protein inhibitor complexes: eglin-c-subtilisin Carlsberg and CI-2-subtilisin Novo.
    McPhalen CA; James MN
    Biochemistry; 1988 Aug; 27(17):6582-98. PubMed ID: 3064813
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Divining the serpin inhibition mechanism: a suicide substrate 'springe'?
    Engh RA; Huber R; Bode W; Schulze AJ
    Trends Biotechnol; 1995 Dec; 13(12):503-10. PubMed ID: 8595135
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bypassing the kinetic trap of serpin protein folding by loop extension.
    Im H; Ahn HY; Yu MH
    Protein Sci; 2000 Aug; 9(8):1497-502. PubMed ID: 10975571
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cloning, expression and characterization of Ostrinia furnacalis serpin1, a regulator of the prophenoloxidase activation system.
    Zhang B; Wu T; Tang X; Zhang S; Xu Q; Zhao Y; Wang Y; Feng C
    Comp Biochem Physiol B Biochem Mol Biol; 2016 Feb; 192():9-20. PubMed ID: 26589634
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of serpin inhibitory function by mutagenesis of ovalbumin and generation of chimeric ovalbumin/PAI-2 fusion proteins.
    McCarthy BJ; Worrall DM
    J Mol Biol; 1997 Apr; 267(3):561-9. PubMed ID: 9126838
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of soluble recombinant furin by human proteinase inhibitor 8.
    Dahlen JR; Jean F; Thomas G; Foster DC; Kisiel W
    J Biol Chem; 1998 Jan; 273(4):1851-4. PubMed ID: 9442015
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiple domains of endopin 2A for serpin cross-class inhibition of papain.
    Hwang SR; Hook VY
    Arch Biochem Biophys; 2007 May; 461(2):219-24. PubMed ID: 17451636
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Viral Serpin Reactive Center Loop (RCL) Peptides: Design and Testing.
    Zhang L; Yaron JR; Ambadapadi S; Lucas A
    Methods Mol Biol; 2018; 1826():133-142. PubMed ID: 30194598
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antichymotrypsin interaction with chymotrypsin. Reactions following encounter complex formation.
    Nair SA; Cooperman BS
    J Biol Chem; 1998 Jul; 273(28):17459-62. PubMed ID: 9651334
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reducing proteolytic liability of a MMP-14 inhibitory antibody by site-saturation mutagenesis.
    Lee KB; Dunn Z; Ge X
    Protein Sci; 2019 Mar; 28(3):643-653. PubMed ID: 30592555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.